Journal article
Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial
Abstract
BACKGROUND: In the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial, some patients with stable ischemic heart disease randomized to optimal medical therapy (OMT) crossed over to early revascularization. The predictors and outcomes of patients who crossed over from OMT to revascularization are unknown.
METHODS AND RESULTS: We compared characteristics of OMT patients who did and did not undergo …
Authors
Spertus JA; Maron DJ; Cohen DJ; Kolm P; Hartigan P; Weintraub WS; Berman DS; Teo KK; Shaw LJ; Sedlis SP
Journal
Circulation Cardiovascular Quality and Outcomes, Vol. 6, No. 4, pp. 409–418
Publisher
Wolters Kluwer
Publication Date
July 2013
DOI
10.1161/circoutcomes.113.000139
ISSN
1941-7713
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedAngina, UnstableCardiovascular AgentsChi-Square DistributionComorbidityCoronary StenosisCross-Over StudiesFemaleHealth StatusHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisNorth AmericaPatient AdmissionPatient SatisfactionPercutaneous Coronary InterventionProportional Hazards ModelsQuality of LifeRisk FactorsSeverity of Illness IndexSurveys and QuestionnairesTime FactorsTreatment Outcome